Establishing the Safety and Efficacy of Reloxaliase (Oxalate Decarboxylase) in Patients with Enteric Hyperoxaluria: A Phase III Randomized, Double-Blind, Placebo-Controlled Study (URIROX-2)

Grants and Contracts Details

StatusFinished
Effective start/end date10/21/20 → 8/8/22

Funding

  • Medpace Inc: $29,558.00